scispace - formally typeset
A

Arndt Hartmann

Researcher at University of Erlangen-Nuremberg

Publications -  1023
Citations -  45826

Arndt Hartmann is an academic researcher from University of Erlangen-Nuremberg. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 93, co-authored 895 publications receiving 35827 citations. Previous affiliations of Arndt Hartmann include University of Basel & University of Jena.

Papers
More filters
Journal ArticleDOI

Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

A. Gordon Robertson, +170 more
- 19 Oct 2017 - 
TL;DR: An analysis of 412 muscle-invasive bladder cancers characterized by multiple TCGA analytical platforms identified 5 expression subtypes that may stratify response to different treatments and identified a poor-survival "neuronal" subtype in which the majority of tumors lacked small cell or neuroendocrine histology.
Journal ArticleDOI

Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

Katherine A Hoadley, +738 more
- 05 Apr 2018 - 
TL;DR: Molecular similarities among histologically or anatomically related cancer types provide a basis for focused pan-cancer analyses, such as pan-gastrointestinal, Pan-gynecological, pan-kidney, and pan-squamous cancers, and those related by stemness features, which may inform strategies for future therapeutic development.
Journal ArticleDOI

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

Franck Pagès, +120 more
- 26 May 2018 - 
TL;DR: The immunoscore provides a reliable estimate of the risk of recurrence in patients with colon cancer and supports the implementation of the consensus Immunoscore as a new component of a TNM-Immune classification of cancer.
Journal ArticleDOI

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.

Jérôme Galon, +56 more
TL;DR: In colorectal cancer, the Immunoscore may add to the significance of the current AJCC/UICC TNM classification, since it has been demonstrated to be a prognostic factor superior to the AJCC or UICCTNM classification.